Alkermes Plc - Company Profile
Powered by 
All the sales intelligence you need on Alkermes Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alkermes Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alkermes Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Alkermes Plc (Alkermes) is an integrated biopharmaceutical company with focus on developing novel therapies for the treatment of chronic diseases including CNS disorders, cancer and addiction. Focuses on R&D activities, diverse product portfolio, and proprietary technology platform are the major strengths of the company, even as overdependence on the US and declining profitability could be a cause for concern to the company. Growing labor costs in US, increasing competitive pressure and changing government regulations could affect the company’s growth and profitability. However, the company could capture growth opportunities through the product pipeline, acquisitions of Avadel Pharmaceuticals Plc, and the market potential of schizophrenia.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer